Agile Therapeutics Inc. (AGRX) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Agile Therapeutics Inc.

NASDAQ: AGRX · Real-Time Price · USD
1.51
0.05 (3.42%)
At close: Aug 22, 2024, 9:58 PM

Agile Therapeutics Revenue

Agile Therapeutics reported an annual revenue of $19.59M, reflecting a undefined% growth. For the quarter ending June 30, 2024, Agile Therapeutics generated $5.58M in revenue.
Revenue (ttm)
n/a
Revenue Growth
n/a
Price / Sales Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.43M

Revenue Chart

History

Fiscal Year End Revenue % Change
Dec 31, 2023 19.59M +80.02%
Dec 31, 2022 10.88M +165.40%
Dec 31, 2021 4.1M +447.53%
Dec 31, 2020 749K +Infinity%
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 n/a
Dec 31, 2015 0 n/a
Dec 31, 2014 0 n/a
Dec 31, 2013 0 n/a
Dec 31, 2012 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.